Cargando…

Punicalagin Protects against Diabetic Liver Injury by Upregulating Mitophagy and Antioxidant Enzyme Activities

Diabetic liver injury has received increasing attention as a serious complication of type 2 diabetes. Punicalagin (PU), a major component of pomegranate polyphenols, has various biological activities such as antioxidant, anti-inflammatory, and lipid metabolism regulation. In this study, we observed...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Yahui, Tan, Xiuying, Cao, Yuan, An, Xin, Chen, Jihua, Yang, Lina
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9319303/
https://www.ncbi.nlm.nih.gov/pubmed/35889739
http://dx.doi.org/10.3390/nu14142782
_version_ 1784755516715565056
author Zhang, Yahui
Tan, Xiuying
Cao, Yuan
An, Xin
Chen, Jihua
Yang, Lina
author_facet Zhang, Yahui
Tan, Xiuying
Cao, Yuan
An, Xin
Chen, Jihua
Yang, Lina
author_sort Zhang, Yahui
collection PubMed
description Diabetic liver injury has received increasing attention as a serious complication of type 2 diabetes. Punicalagin (PU), a major component of pomegranate polyphenols, has various biological activities such as antioxidant, anti-inflammatory, and lipid metabolism regulation. In this study, we observed the protective effect of punicalagin on a high-fat diet (HFD) and streptozotocin (STZ)-induced diabetic liver injury in mice and revealed the underlying mechanism. The results showed that fasting blood glucose (FBG), fasting serum insulin (FINS), and homeostasis model assessment for insulin resistance (HOMA-IR) in diabetic liver injury mice were significantly decreased after punicalagin intervention. Simultaneously, the levels of alanine aminotransferase (ALT), aspartate aminotransferase (AST), total cholesterol (TC), triglyceride (TG), low-density lipoprotein cholesterol (LDL-C), free fatty acids (FFA), malondialdehyde (MDA), and total superoxide dismutase (T-SOD) in the serum and liver were significantly decreased, with reductions in fat lesions and inflammatory cells. Mitophagy is a selective autophagy that maintains a balance between the quality and quantity of intracellular mitochondria. Studies have shown that mitophagy is closely related to the occurrence and development of diabetic liver injury. In our study, the mitochondrial membrane potential (MMP) was significantly increased in mice with diabetic liver injury after punicalagin intervention; the protein expression of Pink1, Parkin, Bnip3, LC3b, P62, manganese superoxide dismutase (MnSOD), and catalase (CAT) was significantly increased in the liver; and the activities of MnSOD and CAT in the serum and liver were significantly increased, which is consistent with the results of in vitro experiments. In summary, our study provided evidence that punicalagin could reduce the level of oxidative stress in the liver by upregulating mitophagy and the activities of antioxidant enzymes, thus having a certain protective effect against diabetic liver injury.
format Online
Article
Text
id pubmed-9319303
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-93193032022-07-27 Punicalagin Protects against Diabetic Liver Injury by Upregulating Mitophagy and Antioxidant Enzyme Activities Zhang, Yahui Tan, Xiuying Cao, Yuan An, Xin Chen, Jihua Yang, Lina Nutrients Article Diabetic liver injury has received increasing attention as a serious complication of type 2 diabetes. Punicalagin (PU), a major component of pomegranate polyphenols, has various biological activities such as antioxidant, anti-inflammatory, and lipid metabolism regulation. In this study, we observed the protective effect of punicalagin on a high-fat diet (HFD) and streptozotocin (STZ)-induced diabetic liver injury in mice and revealed the underlying mechanism. The results showed that fasting blood glucose (FBG), fasting serum insulin (FINS), and homeostasis model assessment for insulin resistance (HOMA-IR) in diabetic liver injury mice were significantly decreased after punicalagin intervention. Simultaneously, the levels of alanine aminotransferase (ALT), aspartate aminotransferase (AST), total cholesterol (TC), triglyceride (TG), low-density lipoprotein cholesterol (LDL-C), free fatty acids (FFA), malondialdehyde (MDA), and total superoxide dismutase (T-SOD) in the serum and liver were significantly decreased, with reductions in fat lesions and inflammatory cells. Mitophagy is a selective autophagy that maintains a balance between the quality and quantity of intracellular mitochondria. Studies have shown that mitophagy is closely related to the occurrence and development of diabetic liver injury. In our study, the mitochondrial membrane potential (MMP) was significantly increased in mice with diabetic liver injury after punicalagin intervention; the protein expression of Pink1, Parkin, Bnip3, LC3b, P62, manganese superoxide dismutase (MnSOD), and catalase (CAT) was significantly increased in the liver; and the activities of MnSOD and CAT in the serum and liver were significantly increased, which is consistent with the results of in vitro experiments. In summary, our study provided evidence that punicalagin could reduce the level of oxidative stress in the liver by upregulating mitophagy and the activities of antioxidant enzymes, thus having a certain protective effect against diabetic liver injury. MDPI 2022-07-06 /pmc/articles/PMC9319303/ /pubmed/35889739 http://dx.doi.org/10.3390/nu14142782 Text en © 2022 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Zhang, Yahui
Tan, Xiuying
Cao, Yuan
An, Xin
Chen, Jihua
Yang, Lina
Punicalagin Protects against Diabetic Liver Injury by Upregulating Mitophagy and Antioxidant Enzyme Activities
title Punicalagin Protects against Diabetic Liver Injury by Upregulating Mitophagy and Antioxidant Enzyme Activities
title_full Punicalagin Protects against Diabetic Liver Injury by Upregulating Mitophagy and Antioxidant Enzyme Activities
title_fullStr Punicalagin Protects against Diabetic Liver Injury by Upregulating Mitophagy and Antioxidant Enzyme Activities
title_full_unstemmed Punicalagin Protects against Diabetic Liver Injury by Upregulating Mitophagy and Antioxidant Enzyme Activities
title_short Punicalagin Protects against Diabetic Liver Injury by Upregulating Mitophagy and Antioxidant Enzyme Activities
title_sort punicalagin protects against diabetic liver injury by upregulating mitophagy and antioxidant enzyme activities
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9319303/
https://www.ncbi.nlm.nih.gov/pubmed/35889739
http://dx.doi.org/10.3390/nu14142782
work_keys_str_mv AT zhangyahui punicalaginprotectsagainstdiabeticliverinjurybyupregulatingmitophagyandantioxidantenzymeactivities
AT tanxiuying punicalaginprotectsagainstdiabeticliverinjurybyupregulatingmitophagyandantioxidantenzymeactivities
AT caoyuan punicalaginprotectsagainstdiabeticliverinjurybyupregulatingmitophagyandantioxidantenzymeactivities
AT anxin punicalaginprotectsagainstdiabeticliverinjurybyupregulatingmitophagyandantioxidantenzymeactivities
AT chenjihua punicalaginprotectsagainstdiabeticliverinjurybyupregulatingmitophagyandantioxidantenzymeactivities
AT yanglina punicalaginprotectsagainstdiabeticliverinjurybyupregulatingmitophagyandantioxidantenzymeactivities